Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops

Completed · Not applicable

Conditions studied: Dry Eye Disease

In brief

The goal of this research is to evaluate and compare the effectiveness of Systane® versus Optive™ on aqueous tear film stability in patients with a diagnosis of Dry Eye Syndrome and to determine the possible application for this product in the future. Systane® is marketed as over-the-counter tear lubricating therapy in the United States under the FDA monograph.

Key facts

Study ID
NCT00610480
Run by
University of Texas Southwestern Medical Center
People needed
20
Starts
2007-11-01
Expected to finish
2009-03-01
Last updated by the study team
2020-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.